Company Announcements Caprotec bioanalytics GmbH named Funakoshi as the exclusive distributor of its research products in Japan. Agilent announced in February that it will exclusively distribute and provide marketing and support for Protein Discovery’s PPS Silent Surfactant, an acid-cleavable, zwitterionic detergent for sample preparation prior to MS. In February, OriGene Technologies announced that it raised […]

IMS Health forecasts the global pharmaceutical market to grow 2.5%–3.5% in 2009, excluding currency effects, to more than $750 billion. This is down from the previous estimate of 4.5%–5.5% growth (see IBO 10/31/08). Compound annual growth for 2009 through 2013 is estimated to be 3%–6%. IMS observed that consumers are less likely to start new […]

Newark, CA 4/23/09; Paris, France 4/24/09—GE has signed a definitive agreement to sell an 81% stake in GE Security’s Homeland Protection business to high-technology firm SAFRAN for $580 million. GE will retain a 19% stake. GE’s Homeland Protection business consists of products for checked-baggage screening, military and critical infrastructure protection, as well as products for […]

In calendar year 2008, Thermo Fisher Scientific retained its position as the number one provider of analytical and life science instruments and aftermarket products, according to IBO’s annual calculation of the top 30 companies. The top 30 companies generated an estimated $26.6 billion in sales of analytical and life science instruments and aftermarket products last […]

The cosmetics and personal care market is a bright spot for many chemical companies during the recession. Univar Personal, Gelest and Rhodia are among the firms that have indicated continuing demand for cosmetic and personal care products and ingredients. However, customers are switching to more cost-effective brands and products. To continue to attract customers and […]

R&D spending by members of the Pharmaceutical Research and Manufacturers of America (PhRMA) increased 4.9% last year to an estimated $50,253.6 million. Domestic R&D spending rose 5.0% to $38,437.8 million and foreign R&D climbed 4.7% to $11,825.7 million. As a percentage of sales, R&D expenditures totaled 17.4%, compared to 17.5% in 2007. In 2007, PhRMA […]

Company Announcements MoBiTec GmbH agreed to distribute NIZO’s NICE (NIsin Controlled Gene Expression Systems) system for controlled gene expression in L. lactis. Luminex COO Douglas C. Bryant resigned in January to become president and CEO of Quidel. Sequenom named Allan T. Bombard, MD, to the newly created position of chief medical officer in January. Previously, […]